Dashboard
Manage Tickers

CTKB


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cytek-biosciences-announces-the-relocation-of-its-european-headquarters-to-a-new-facility-in-amsterdams-life-sciences-district
Cytek Biosciences Announces The Relocation...
10/15/2025 21:04:49

FREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that strengthens its European operations and enhances service for ...

cytek-biosciences-narrows-fy2025-sales-guidance-from-196000m-210000m-to-196000m-205000m-vs-198301m-est
Cytek Biosciences Narrows FY2025 Sales Gui...
08/06/2025 20:28:43

Cytek Biosciences (NASDAQ:CTKB) narrows FY2025 sales outlook from $196.000 million-$210.000 million to $196.000 million-$205.00...

cytek-biosciences-q2-eps-004-inline-sales-45602m-miss-46479m-estimate
Cytek Biosciences Q2 EPS $(0.04), Inline, ...
08/06/2025 20:11:18

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This i...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

cytek-biosciences-launches-cytek-aurora-evo-system-a-new-full-spectrum-flow-cytometer
Cytek Biosciences Launches Cytek Aurora Ev...
05/29/2025 21:05:23

beyond-the-numbers-4-analysts-discuss-cytek-biosciences-stock
Beyond The Numbers: 4 Analysts Discuss Cyt...
05/28/2025 19:00:32

morgan-stanley-maintains-equal-weight-on-cytek-biosciences-lowers-price-target-to-7
Morgan Stanley Maintains Equal-Weight on C...
05/28/2025 16:11:15

Morgan Stanley analyst Tejas Savant maintains Cytek Biosciences (NASDAQ:CTKB) with a Equal-Weight and lowers the price targe...

dht-holdings-posts-weak-sales-joins-compass-diversified-okta-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
DHT Holdings Posts Weak Sales, Joins Compa...
05/28/2025 12:24:06

goldman-sachs-maintains-sell-on-cytek-biosciences-lowers-price-target-to-3
Goldman Sachs Maintains Sell on Cytek Bios...
05/12/2025 17:03:46

Goldman Sachs analyst Matthew Sykes maintains Cytek Biosciences (NASDAQ:CTKB) with a Sell and lowers the price target from $...

cytek-biosciences-lowers-fy2025-sales-guidance-from-20400m-21200m-to-19600m-21000m-vs-20443m-est
Cytek Biosciences Lowers FY2025 Sales Guid...
05/08/2025 20:43:44

Cytek Biosciences (NASDAQ:CTKB) lowers FY2025 sales outlook from $204.00 million-$212.00 million to $196.00 million-$210.00 mil...

cytek-biosciences-q1-eps-009-misses-004-estimate-sales-5193m-beat-4266m-estimate
Cytek Biosciences Q1 EPS $(0.09) Misses $(...
05/08/2025 20:26:00

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

cytek-biosciences-showcases-its-patented-full-spectrum-profiling-technology-at-cyto-and-immunology2025
Cytek Biosciences Showcases Its Patented F...
04/29/2025 21:05:15

stephens--co-reiterates-overweight-on-cytek-biosciences-maintains-6-price-target
Stephens & Co. Reiterates Overweight on Cy...
03/19/2025 14:07:32

Stephens & Co. analyst Mason Carrico reiterates Cytek Biosciences (NASDAQ:CTKB) with a Overweight and maintains $6 price...

piper-sandler-maintains-overweight-on-cytek-biosciences-lowers-price-target-to-8
Piper Sandler Maintains Overweight on Cyte...
03/04/2025 15:45:54

Piper Sandler analyst David Westenberg maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and lowers the price targ...

cytek-biosciences-sees-fy2025-sales-204000m-212000m-vs-21960m-est
Cytek Biosciences Sees FY2025 Sales $204.0...
02/27/2025 21:24:25

Cytek Biosciences (NASDAQ:CTKB) sees FY2025 sales of $204.000 million-$212.000 million vs $219.60 million analyst estimate.

cytek-biosciences-q4-eps-007-beats-005-estimate-sales-5748m-miss-5938m-estimate
Cytek Biosciences Q4 EPS $0.07 Beats $0.05...
02/27/2025 21:23:38

Cytek Biosciences (NASDAQ:CTKB) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0....

earnings-scheduled-for-february-27-2025
Earnings Scheduled For February 27, 2025
02/27/2025 08:32:34

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/31/2025 21:06:18

cytek-anticipates-2024-revenue-between-200m-201m-4-growth-over-2023-q4-revenue-expected-at-57m-58m-11-13-rise-from-q3-amid-15m-impact-from-stronger-usd
Cytek Anticipates 2024 Revenue Between $20...
01/15/2025 13:11:01

Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenu...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION